DK0659767T3 - Fremgangsmåde til fremstilling af et koncentrat af anti-D-immunoglobulin G og et farmaceutisk præparat, som indeholder dett - Google Patents

Fremgangsmåde til fremstilling af et koncentrat af anti-D-immunoglobulin G og et farmaceutisk præparat, som indeholder dett

Info

Publication number
DK0659767T3
DK0659767T3 DK93810912T DK93810912T DK0659767T3 DK 0659767 T3 DK0659767 T3 DK 0659767T3 DK 93810912 T DK93810912 T DK 93810912T DK 93810912 T DK93810912 T DK 93810912T DK 0659767 T3 DK0659767 T3 DK 0659767T3
Authority
DK
Denmark
Prior art keywords
igg
adsorbent
plasma
immunoglobulin
concentrate
Prior art date
Application number
DK93810912T
Other languages
English (en)
Other versions
DK0659767T4 (da
Inventor
Martin Dr Stucki
Peter Dr Lerch
Gerhard Hodler
Original Assignee
Rotkreuzstiftung Zentrallab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8215103&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0659767(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Rotkreuzstiftung Zentrallab filed Critical Rotkreuzstiftung Zentrallab
Application granted granted Critical
Publication of DK0659767T3 publication Critical patent/DK0659767T3/da
Publication of DK0659767T4 publication Critical patent/DK0659767T4/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/34—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK93810912T 1993-12-27 1993-12-27 Fremgangsmåde til fremstilling af et koncentrat af anti-D-immunoglobulin G og et farmaceutisk præparat, som indeholder dette DK0659767T4 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93810912A EP0659767B2 (de) 1993-12-27 1993-12-27 Verfahren zur Herstellung eines Konzentrates von Anti-D-Immunoglobulin G und pharmazeutische Zusammensetzung, die dieses enthält

Publications (2)

Publication Number Publication Date
DK0659767T3 true DK0659767T3 (da) 1999-09-13
DK0659767T4 DK0659767T4 (da) 2003-02-10

Family

ID=8215103

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93810912T DK0659767T4 (da) 1993-12-27 1993-12-27 Fremgangsmåde til fremstilling af et koncentrat af anti-D-immunoglobulin G og et farmaceutisk præparat, som indeholder dette

Country Status (20)

Country Link
US (1) US5593675A (da)
EP (1) EP0659767B2 (da)
JP (1) JP2926463B2 (da)
KR (1) KR100368563B1 (da)
AT (1) ATE175979T1 (da)
AU (1) AU682243B2 (da)
CA (1) CA2138921C (da)
CZ (1) CZ286271B6 (da)
DE (1) DE59309332D1 (da)
DK (1) DK0659767T4 (da)
ES (1) ES2129076T5 (da)
FI (1) FI112168B (da)
GR (1) GR3029817T3 (da)
HU (1) HU216864B (da)
NO (1) NO315331B1 (da)
NZ (1) NZ278057A (da)
PL (1) PL180358B1 (da)
SI (1) SI9420008B (da)
TW (1) TW311884B (da)
WO (1) WO1995018155A1 (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ507557A (en) * 1998-05-06 2003-10-31 Genentech Inc Protein purification by ion exchange chromatography
DK2270044T3 (da) * 1998-06-09 2015-01-26 Csl Behring Ag Flydende immunglobulin G (IgG) produkt
DE19923027C2 (de) * 1999-05-19 2002-09-19 Aventis Behring Gmbh Verfahren zur Inaktivierung von Viren
US6475749B1 (en) * 1999-08-11 2002-11-05 The Regents Of The University Of California Rh hybrid antibody
SE0001128D0 (sv) * 2000-03-30 2000-03-30 Amersham Pharm Biotech Ab A method of producing IgG
ES2184594B1 (es) 2001-01-17 2004-01-01 Probitas Pharma Sa Procedimiento para la produccion de gammaglobulina g humana inactivada de virus.
EP1532983A1 (en) * 2003-11-18 2005-05-25 ZLB Bioplasma AG Immunoglobulin preparations having increased stability
CA2458750C (en) 2004-02-23 2012-02-07 Bayer Inc. Isoolefin-diolefin production process and apparatus therefor
EP1885755A4 (en) * 2005-05-05 2009-07-29 Univ Duke CD19 ANTIBODY THERAPY FOR AUTOIMMUNE DISEASES
TWI320788B (en) 2005-05-25 2010-02-21 Hoffmann La Roche Method for the purification of antibodies
SI2061803T2 (sl) * 2006-08-28 2023-01-31 Ares Trading S.A. Postopek za čiščenje proteinov, ki vsebujejo FC
WO2008025747A1 (en) * 2006-08-28 2008-03-06 Ares Trading S.A. Process for the purification of fc-fusion proteins
IT1397061B1 (it) * 2009-12-28 2012-12-28 Kedrion Spa Nuovo processo di purificazione su scala industriale di gammaglobuline da plasma umano per uso industriale.
WO2011095543A1 (en) 2010-02-04 2011-08-11 Csl Behring Ag Immunoglobulin preparation
EP2361636A1 (en) 2010-02-26 2011-08-31 CSL Behring AG Immunoglobulin preparation and storage system for an immunoglobulin preparation
RU2467783C2 (ru) * 2010-07-30 2012-11-27 Закрытое акционерное общество "БиоХимМак СТ" Способ хроматографического выделения иммуноглобулина
US20120076779A1 (en) * 2010-09-17 2012-03-29 Baxter Healthcare S.A. STABILIZATION OF IMMUNOGLOBULINS AND OTHER PROTEINS THROUGH AQUEOUS FORMULATIONS WITH SODIUM CHLORIDE AT WEAK ACIDIC TO NEUTRAL ph
SG11201400233TA (en) * 2011-08-26 2014-08-28 Baxter Int Method for reducing the thromboembolic potential of a plasma-derived immunoglobulin composition
AU2013203043B2 (en) * 2013-03-15 2016-10-06 Takeda Pharmaceutical Company Limited Methods to produce a human plasma-derived igg preparation enriched in brain disease-related natural iggs
KR101917196B1 (ko) * 2014-03-11 2018-11-09 주식회사 녹십자홀딩스 면역글로불린의 정제방법
KR101917197B1 (ko) * 2014-03-11 2018-11-09 주식회사 녹십자홀딩스 면역글로불린의 정제방법
ES2988823T3 (es) 2014-12-03 2024-11-21 Csl Behring Ag Producto farmacéutico con mayor estabilidad que comprende inmunoglobulinas
EP3810649A1 (en) * 2018-06-22 2021-04-28 Genmab A/S Method for producing a controlled mixture of two or more different antibodies
EP4349859A1 (en) * 2023-01-27 2024-04-10 CSL Behring AG Method to purify anti-d immunoglobulin g from plasma
EP4655316A1 (en) * 2023-01-27 2025-12-03 CSL Behring AG Method for reducing protease activity in a solution comprising anti-d immunoglobulin g

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3869436A (en) * 1971-06-01 1975-03-04 Statens Bakteriologiska Lab Method for fractionating plasma proteins using peg and ion-exchangers
EP0085747B2 (de) * 1982-02-08 1990-05-30 Schweizerisches Serum- und Impfinstitut und Institut zur Erforschung der Infektionskrankheiten Intravenös verabreichbares humanes Immunglobulin und Verfahren zu dessen Herstellung
US4434093A (en) * 1982-07-26 1984-02-28 Ortho Diagnostic Systems Inc. Methods for preparation of HBs Ag free gamma globulins
DE3640513A1 (de) * 1986-11-27 1988-06-09 Biotest Pharma Gmbh Verfahren zur herstellung eines virussicheren, lagerstabilen und intravenoes vertraeglichen immunglobulin-g-praeparates
US5118796A (en) * 1987-12-09 1992-06-02 Centocor, Incorporated Efficient large-scale purification of immunoglobulins and derivatives
US5138034A (en) * 1989-07-12 1992-08-11 The Green Cross Corporation Method of fractionating plasma proteins
US5177194A (en) * 1990-02-01 1993-01-05 Baxter International, Inc. Process for purifying immune serum globulins

Also Published As

Publication number Publication date
HU9502514D0 (en) 1995-11-28
JP2926463B2 (ja) 1999-07-28
CA2138921A1 (en) 1995-06-28
CA2138921C (en) 2004-11-02
PL180358B1 (pl) 2001-01-31
EP0659767B2 (de) 2002-11-06
WO1995018155A1 (en) 1995-07-06
SI9420008B (sl) 1998-06-30
HU216864B (hu) 1999-09-28
HUT73376A (en) 1996-07-29
GR3029817T3 (en) 1999-06-30
NO945032D0 (no) 1994-12-23
NZ278057A (en) 1997-03-24
FI112168B (fi) 2003-11-14
FI946103L (fi) 1995-06-28
JPH07206708A (ja) 1995-08-08
EP0659767B1 (de) 1999-01-20
CZ286271B6 (cs) 2000-03-15
CZ249295A3 (en) 1996-01-17
EP0659767A1 (de) 1995-06-28
TW311884B (da) 1997-08-01
NO315331B1 (no) 2003-08-18
DE59309332D1 (de) 1999-03-04
FI946103A0 (fi) 1994-12-27
DK0659767T4 (da) 2003-02-10
ES2129076T3 (es) 1999-06-01
US5593675A (en) 1997-01-14
AU682243B2 (en) 1997-09-25
NO945032L (no) 1995-06-28
ES2129076T5 (es) 2003-05-16
AU1414395A (en) 1995-07-17
KR960701098A (ko) 1996-02-24
SI9420008A (en) 1996-02-29
ATE175979T1 (de) 1999-02-15
KR100368563B1 (ko) 2003-04-03
PL310435A1 (en) 1995-12-11

Similar Documents

Publication Publication Date Title
DK0659767T3 (da) Fremgangsmåde til fremstilling af et koncentrat af anti-D-immunoglobulin G og et farmaceutisk præparat, som indeholder dett
NZ509135A (en) A third generation intravenous immunoglobulin G (IVIG) purified using column chromatographic ion exchange methods
EP0352500A3 (en) Polyclonal immunoglobulin-based intravenous preparation with a high igm content, and method for its production
ES2081742B1 (es) Procedimiento para preparar inmunoglobulina purificada.
CA2183888A1 (en) Antibody purification
CA2200301A1 (en) Method for fractionation of sucrose-containing solutions
EP0530447A3 (en) Process for purifying igg monoclonal antibodies and their use
CS275600B2 (en) Method of purified albumin preparation from human or animal physiological solution
EP0385118A3 (en) Use of compounds containing or binding sialic acid to neutralize bacterial toxins
EP0660932A4 (en) METHOD FOR PRODUCING TEST ELEMENTS.
DE3914869C1 (da)
CA2213577A1 (en) A process for the preparation of factor ix from biological sources
DK0555135T3 (da) Fremgangsmåde til fremstilling af fibrinogen med meget høj renhed, således fremstillet fibrinogen med meget høj renhed, samt et farmaceutisk præparat med indhold deraf
RU95112503A (ru) Способ выделения предварительно отобранного гемоглобина и очищенный препарат гемоглобина
CA2096888A1 (en) Process for the inactivation of viruses in preparations of proteins
NO915032L (no) Interferonrenseprosess
GB9001593D0 (en) Thiophilic absorbents
JPS54126788A (en) Prepapration of human lyzozyme
FI935161L (fi) Menetelmä plasmaproteiinien TTR ja RBP eristämiseksi ja jatkopuhdistamiseksi